Tag: preclinical
-
Covid-19 Vaccine Shown Active Against Variants
Moderna Inc., developer of a vaccine to prevent Covid-19 disease, says lab test results show antibodies from the vaccine neutralize two recently found viral mutations.
-
Multi-Variant Covid-19 Vaccine in the Works
A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon.
-
Biotech Licenses mRNA Technology for Aging
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging.
-
Vaccine Shown Active Against New Covid-19 Variants
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K.
-
Synthetic Virus Company Forms, Raises $77M
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute.
-
FDA Issues Precision Genomic Drug Guidance
The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies.
-
Small Biz Grant Funds Heat-Stable Multi-Virus Vaccine
A biotechnology company is receiving a federal grant for a vaccine in freeze-dried form to prevent infections from Covid-19 and Ebola viruses.
-
Device-Aided Covid-19 Vaccine Invokes Immune Response
Results from an early clinical trial show a Covid-19 vaccine using an electronic device to boost uptake in cells is safe and generates an immune-system response.
-
Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant
A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.